DUBLIN--(BUSINESS WIRE)--The "Keratometers Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022-2027)" report has been added to ResearchAndMarkets.com's offering.
The global keratometers market is projected to register a CAGR of 4.2% during the forecast period (2022-2027).
The COVID-19 pandemic led to disruption in not only in the research and development activities of other therapies and drugs but for medical conditions other than COVID-19 were also impacted the treatment procedures and supply chain of the pharmaceuticals and medical devices around the world which also impacted the studied market of keratometers market.
For instance, in November 2021, a research study published titled "Impact of COVID-19 pandemic on cataract surgical volume: A North Indian experience" stated that in 2020, it was expected to perform 7500 cases (assuming historical trends) but performed only 2500 cases (33% of the expected volume). The remaining 5000 cases (67% cases) constituted the "fixed" backlog. Hence, an intuitive approach and out-of-the-box solutions are required by the government and private institutes' collaborative efforts to help mitigate the disruptions caused by the pandemic and lessen the backlog without causing provider burnout.
Similarly, another research study published in June 2020 titled "The new normal for cataract and refractive surgery due to COVID-19 (SARS-CoV-2)" stated that with the exception of some emergency anterior surgeries, cataract and refractive surgery is considered to be elective in most countries. Therefore, the overall impact of the COVID-19 on the market was negative primarily due to the decline in the diagnostics and treatment procedures of the diseases associated with the eye but with the ongoing vaccination programs and launch of new drugs against the COVID-19, the studied market is expected to beam back to its full potential in due time.
According to the October 2021 report of the World Health Organization, about 2.2 billion people around the world have near or distance vision impairment, of which approximately 1 billion cases of vision impairment can be prevented or could have been prevented which shows the high burden of the cases of vision impairment around the world and possibility of treatment which is why there is a very high demand of the diagnostics and therapeutics for the diseases associated with eyes that are driving the growth of the studied market. The article published in February 2020, titled "The Statistics on Eye Disease in America (2022)" stated that in the United States alone, about 12 million people age 40 and above suffer from vision impairment, with about a million suffering from blindness. The Centers for Disease Control and Prevention (CDC) reports that 17.2 percent of Americans over 40 years of age have a cataract in at least one eye (about 20.5 million people). By 2028, it is expected that over 30 million people will have cataracts.
Surgery is the most recommended treatment option for dealing with cataracts. Only about 6.1 million Americans have had their lenses surgically removed and replaced with new lenses to address their cataracts, according to the CDC. India was the first country to launch the National Programme for Control of Blindness in 1976 to reduce blindness prevalence to 0.3 per cent by 2020. But, the estimated prevalence of blindness still stands at 1.99 per cent, severe visual impairment at 1.96 per cent, moderate visual impairment at 9.81 per cent and moderate severe visual impairment at 11.77 per cent, according to the survey released on October 10, 2019. Thus, the demand for effective therapeutics and diagnostics is also expected to increase around the world that is expected to drive the growth in the studied market. Therefore, owing to the increasing burden of the eye disorders and associated risk factors across the world, the market is expected to grow during the forecast period of the study.
However, the lack of primary infrastructure for eye related diseases in underdeveloped and developing countries is hampering the overall market growth.
Key Market Trends
- Hospitals Expected to Hold a Significant Market Share Over the Forecast Period
- North America Expected to Dominate the Market Over the Forecast Period
Competitive Landscape
The market is partially fragmented and consists of several major players. Some of the companies which are currently dominating the market are Carl Zeiss AG, Essilor, Luneau, Reichert Technologies, and NIDEK Co. Ltd. among others.
Key Topics Covered
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Burden of Eye Disorders
4.2.2 Growing Investments, Funds, and Grants
4.3 Market Restraints
4.3.1 Lack of Primary Infrastructure For Eye Related Diseases in Underdeveloped and Developing Countries
4.4 Porter's Five Force Analysis
5 MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Type
5.1.1 Stationary Type Keratometers
5.1.2 Portable Type Keratometers
5.2 Indication
5.2.1 Hospitals
5.2.2 Eye Clinics
5.2.3 Others
5.3 Geography
5.3.1 North America
5.3.2 Europe
5.3.3 Asia-Pacific
5.3.4 Middle East & Africa
5.3.5 South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Carl Zeiss AG
6.1.2 Costruzione Strumenti Oftalmici
6.1.3 Essilor
6.1.4 Luneau
6.1.5 Mehra Eyetech Pvt. Ltd.
6.1.6 Micro Medical Devices
6.1.7 Naugra Medical
6.1.8 NIDEK Co. Ltd.
6.1.9 Quantel Medical
6.1.10 Reichert Technologies
6.1.11 Shigiya Machinery Works Ltd. - GS Division
6.1.12 WECI
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/r/a23g70
